SCHEMBL6492258

SCHEMBL6492258

CCOC(=O)c1c(C)cccc1COc1cc(C)c2nc(C)n(Cc3ncc(Cl)cc3Cl)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPT P10636 6/20 0.34
LMNA P02545 2/20 0.34
GAA P10253 1/20 0.34
PIK3C2B O00750 2/20 0.34
DCTPP1 Q9H773 2/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
NPY1R P25929 1/20 0.33
TP53 P04637 2/20 0.33
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6495279 0.93 MAPT (0.36) ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL6501064 0.91 PIK3C2B (0.38) PIK3C2BDCTPP1MEN1KMT2APPARG
SCHEMBL6496340 0.89 PPARG (0.41) ALDH1A1MAPTLMNASMN1; SMN2TP53
SCHEMBL6487607 0.85 REN (0.38) PIK3C2BDCTPP1PPARG
SCHEMBL6492991 0.85 DCTPP1 (0.36) KDM4EMAPTPIK3C2BDCTPP1SMN1; SMN2
SCHEMBL6488710 0.84 BCL2 (0.39) ALDH1A1MAPTDCTPP1TP53
SCHEMBL6491005 0.84 BCL2 (0.47) PIK3C2BTP53
SCHEMBL6500609 0.84 DCTPP1 (0.38) ALDH1A1MAPTGAAPIK3C2BDCTPP1
SCHEMBL6491725 0.83 PIK3C2B (0.37) PIK3C2BDCTPP1
SCHEMBL6503787 0.81 PIK3C2B (0.38) PIK3C2BDCTPP1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD ALDH1A1 96/4885KDM4E 760/4885CYP1A2 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.